Sign in to view content

ADVM-022 Intravitreal Gene Therapy for Neovascular AMD: Phase 1 OPTIC Trial Update

Dante Joseph Pieramici, MD

Video
Published 2022

Related

Intraoperative Use of Microscope-Integrated OCT for Subretinal Gene Therapy
Ninel Z. Gregori, MD
Annual Meeting Talks
2018
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew Starr, MD
Updates from the Field
2021
Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics
Murtaza K Adam, MD
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more